Ertugliflozin Pidolate

Overview

Ertugliflozin Pidolate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5315054).

API suppliers (6)

Suppliers of Ertugliflozin Pidolate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia2 active DMF
• HIKAL LTDPakistan1 active DMF
• Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• HONOUR LAB LTDIndia1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Ertugliflozin Pidolate expires 19 Dec 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid

Canonical SMILES

CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl.C1CC(=O)N[C@@H]1C(=O)O

InChIKey

YHIUPZFKHZTLSH-LXYIGGQGSA-N